For decades, progress in oncology has been driven by pioneering institutions that recognize and invest in emerging fields. Through the study of tumor biology, immunology, genetics and precision medicine, we have reshaped cancer care — and it has made a lifesaving difference. Mortality rates have declined and treatments are extending not only years of life, but also quality of life. That progress did not happen by chance; it was the result of del…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.